期刊文献+

住院患者医院感染肠球菌属的分布与耐药性分析 被引量:5

The distribution and drug resistance analysis of Enterococcus faecalis and Enterococcus faecium
原文传递
导出
摘要 目的:分析医院感染粪肠球菌与屎肠球菌的分布及其耐药性,为临床有针对性采取预防措施、合理用药提供可靠依据。方法对2010-2012年医院患者送检标本培养出的粪肠球菌、屎肠球菌采用的法国生物梅里埃公司的VITEK‐60全自动细菌鉴定分析仪进行鉴定,药物敏感试验采用 K‐B纸片扩散法,采用统计分析软件SPSS16.0进行数据统计分析。结果共培养出149株粪肠球菌和120株屎肠球菌,其中重症医学科较高分别占20.81%、30.83%;主要分布在<10岁及50~80岁患者;肠球菌属在尿液、分泌物、脓液、血液、痰液、腹水、胆汁检出率较高;粪肠球菌对万古霉素、替考拉宁、利奈唑胺敏感率分别为100.00%、98.66%,对红霉素、四环素耐药率分别为77.85%、69.13%;屎肠球菌对万古霉素、替考拉宁、利奈唑胺敏感率分别为100.00%、100.00%、98.33%,对红霉素、青霉素G、氨苄西林等抗菌药物耐药性较高,分别为97.50%、96.67%、96.67%。结论不同科室、年龄、送检标本中肠球菌属分布不同,对不同抗菌药物敏感度不同,因此,应采取针对性措施,以降低肠球菌属感染发生率。 OBJECTIVE To analyze the distribution and drug resistance of Enterococcus f aecalis and Enterococcus f aecium in a three level of first‐class hospital so as to provide a reliable basis for rational use of drugs and preven‐tive measures in clinical .METHODS The distribution and drug resistance were measured by VITEK‐60 automatic bacteria analyzer produced by Biomerieux from 2010 to 2012 .The data obtained were analyzed by SPSS 16 .0 soft‐ware .RESULTS Totally 149 strains of E .f aecalis and 120 strains of E .f aecium were cultured in different depart‐ments .ICU was found to have the most bacteria ,accounting for 20 .81% and 30 .83% respectively .Patients were mainly under the age of 10 or between 50 and 80 years old .Enterococci were mainly in urine ,secretions ,fester , blood ,sputum ,ascites and bile .E .f aecalis was sensitive to vancomycin (100 .00% ) ,teicoplanin (98 .66% ) ,lin‐ezolid (99 .33% ) and resistant to erythromycin (77 .85% ) ,tetracycline (69 .13% ) ,ciprofloxacin (48 .32% ) ,rif‐ampicin (42 .28% ) and levofloxacin (41 .61% ) .E .f aecium was sensitive to vancomycin (100 .00% ) ,teicoplanin (100 .00% ) ,linezolid (98 .33% ) and resistant to erythromycin (97 .50% ) ,penicillin G (96 .67% ) ,ampicillin (96 .67% ) ,tetracycline (74 .17% ) ,ciprofloxacin (89 .17% ) ,levofloxacin (84 .17% ) and rifampicin (74 .17% ) . CONCLUSION Enterococcus distribution varies in different departments ,different ages anrd different specimens . E .f aecalis and E .f aecium have different sensitivity to different antibiotics .Therefore ,specific measures should be taken in departments and age phases with high detection rate .The specimen detection should be strengthened . The antibiotics should be chosen reasonably according to the drug sensitivity results .In this way the incidence in‐fection rate of E .f aecalis and E .f aecium will reduce correspondingly .
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2015年第13期2917-2919,共3页 Chinese Journal of Nosocomiology
基金 山东省高校科技计划基金资助项目(J13LK15) 滨州市科技发展计划基金资助项目(2013ZC714 2013ZC1802)
关键词 医院感染 粪肠球菌 屎肠球菌 耐药性 Hospital infection Enterococcus f aecalis Enterococcus f aecium Drug resistance
  • 相关文献

参考文献8

二级参考文献50

共引文献585

同被引文献48

  • 1医院感染诊断标准(试行)摘登(1)[J].新医学,2005,36(8):495-495. 被引量:217
  • 2Clinical, Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing [ S ]. Twenty- Fourth Informational Supplement ,2014 : M100-$24.
  • 3Padmavathy K, Praveen S, Madhavan R, et al. Clinico-microbi- ological investigation of catheter-associated urinary tract infec- tion by Enterococcus faecalis: vanA genotype [ J ]. Clin Diagn Res, 2015,9 ( 8 ) : DD05-DD06.
  • 4Ntokou E, Stathopoulos C, Kristo I, et al. Intensive care unit dissemination of multiple clones of linezolid-resistant Entero- coccus faecalis and Enterococcus faecium [ J ]. J Antimicrob Chemother,2012,67 ( 8 ) : 1819-1823.
  • 5LUthje P, Linden HA, Brauner A. Estrogenic action on innate defense mechanisms in the urinary tract[ J ]. Maturitas,2014, 77( 1 ) :32-36.
  • 6Kim YG, Shaw MH, Warner N, et al. Cutting edge: Crohn' s disease-associated Nod2 mutation limits production of proin- flammatory cytokines to protect the host from Enterococcus faecalis induced lethality [ J ]. J Immunol,2011,187 ( 6 ) : 2849 - 2852.
  • 7Hegstad K, Giske CG, Haldorsen B, et al. Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Entemcocci with low- and medium-level Vard3-type vancomycin resistance: a mulficenter study [ J ]. J Clin Microbiol, 2014,52 ( 5 ) : 1582- 1589.
  • 8Hayakawa K, Marchaim D, Palla M, et al. Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-con- trol study [ J]. Antimicrob Agents Chemother, 2013,57 ( 1 ) : 49-55.
  • 9Brandon M, Dowzicky MJ. Antimicrobial susceptibility among gram-positive organisms collected from pediatric patients glob- ally between 2004 and 2011 :results from the Tigecycline Eval- uation and Surveillance Trial [ J ]. J Clin Microbiol, 2013,51 (7) :2371-2378.
  • 10Pericas JM, Cervera C, Del RA, et al. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone [ J ]. Clin Microbiol Infect, 2014,20 ( 12 ) : 1075-1083.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部